March 2024
1. WANG Y, Peng X
   Bioinformatics analysis characterizes immune infiltration landscape and identifies potential blood biomarkers for heart transplantation.
   Transpl Immunol. 2024 Mar 16:102036. doi: 10.1016/j.trim.2024.102036.
   

   >> Share

   
   
2. WANG H, Mao X, Zhong Y, Zhao X, et al
   Human amniotic mesenchymal stem cells inhibit immune rejection injury from allogeneic mouse heart transplantation: A preliminary study on the microRNA expression.
   Transpl Immunol. 2024 Mar 5:102022. doi: 10.1016/j.trim.2024.102022.
   

   >> Share

   
   February 2024
3. ALAM A, van Zyl JS, Patel R, Jamil AK, et al
   Three-year outcomes of de novo tacrolimus extended-release tablets (LCPT) compared to twice-daily tacrolimus in adult heart transplantation.
   Transpl Immunol. 2024 Feb 5:102009. doi: 10.1016/j.trim.2024.102009.
   

   >> Share

   
   September 2023
4. KUCZAJ A, Warwas S, Zakliczynski M, Pawlak S, et al
   Does the induction immunotherapy (basiliximab) influence the early acute cellular rejection index after orthotopic heart transplantation?- Preliminary assessment report.
   Transpl Immunol. 2023 Sep 29:101937. doi: 10.1016/j.trim.2023.101937.
   

   >> Share

   
   August 2023
5. ALAM A, Van Zyl J, Mckean S, Abdelrehim A, et al
   Rejection! Or is it? Correlation among molecular microscope diagnostic system, histopathology and clinical judgement following heart transplantation.
   Transpl Immunol. 2023 Aug 28:101924. doi: 10.1016/j.trim.2023.101924.
   

   >> Share

   
   
6. TESZAK T, Assabiny A, Kiraly A, Tarjanyi Z, et al
   Extracorporeal photopheresis in the treatment of cardiac allograft rejection: A single-centre experience.
   Transpl Immunol. 2023;79:101853.
   

   >> Share

   
   
7. CREMEN S, Santiago RM, Robinson MW, Gallagher TK, et al
   Biomarkers of biological aging in recipients of solid organ transplantation and clinical outcomes: A scoping review.
   Transpl Immunol. 2023;79:101851.
   

   >> Share

   
   March 2023
8. CHOU-WU E, Kemna M, Ross S, Youngs D, et al
   Association of MICA and AT1R antibodies with antibody mediated rejection and cardiac allograft vasculopathy in a pediatric heart transplant recipient.
   Transpl Immunol. 2023 Mar 6:101811. doi: 10.1016/j.trim.2023.101811.
   

   >> Share

   
   December 2022
9. GRILLE-CANCELA Z, Barge-Caballero E, Suarez-Fuentetaja N, Domenech-Garcia N, et al
   Soluble HLA-G levels in heart transplant recipients: Dynamics and correlation with clinical outcomes.
   Transpl Immunol. 2022 Dec 3:101771. doi: 10.1016/j.trim.2022.101771.
   

   >> Share

   
   November 2022
10. ZHOU Y, Huang X, Liu L, Zeng F, et al
    Effect of Wuzhi preparations on tacrolimus in CYP3A5 expressers during the early period after transplantation: A real-life experience from heart transplant recipients.
    Transpl Immunol. 2022 Nov 21:101748. doi: 10.1016/j.trim.2022.101748.
    

    >> Share

    
    October 2022
11. OSCHERWITZ M, Nguyen HQ, Raza SS, Cleveland DC, et al
    Will previous palliative surgery for congenital heart disease be detrimental to subsequent pig heart xenotransplantation?
    Transpl Immunol. 2022;74:101661.
    

    >> Share

    
    September 2022
12. MCCUNE TR, Bray RA, Baran DA, Toepp AJ, et al
    Development of donor specific antibodies after SARS-CoV-2 vaccination in kidney and heart transplant recipients.
    Transpl Immunol. 2022;75:101722.
    

    >> Share

    
    
13. GAVROY B, Timmermans T, Van Caenegem O, Mastrobuoni S, et al
    Significance of HLA-matching and anti-HLA antibodies in heart transplant patients receiving induction therapy?
    Transpl Immunol. 2022;75:101706.
    

    >> Share

    
    
14. YANG BQ, Vader JM, Lambert DS, Petrella R, et al
    COVID-19 in orthotopic heart transplant recipients and association with donor specific antibodies.
    Transpl Immunol. 2022 Sep 10:101712. doi: 10.1016/j.trim.2022.101712.
    

    >> Share

    
    July 2022
15. LU L, Shi M, Qiu J, Shi Z, et al
    ZBTB20 regulates cardiac allograft rejection through NFsmall ka, CyrillicB-mediated inflammation in mouse heart transplantation.
    Transpl Immunol. 2022 Jul 21:101676. doi: 10.1016/j.trim.2022.101676.
    

    >> Share

    
    March 2022
16. CHAU VQ, Feinman J, Fullin K, Mahmood K, et al
    De novo human leukocyte antigen allosensitization patterns in patients bridged to heart transplantation using left ventricular assist devices.
    Transpl Immunol. 2022;72:101567.
    

    >> Share

    
    December 2021
17. CHAIDAROGLOU A, Armenis I, Gkouziouta A, Bonios MJ, et al
    The effect of paracorporeal pulsatile biventricular assist devices on allosensitization in adults: A comparison with left ventricular assist devices.
    Transpl Immunol. 2021;69:101477.
    

    >> Share

    
    October 2021
18. MATAR AJ, Crepeau RL, Duran-Struuck R
    Non-invasive imaging for the diagnosis of acute rejection in transplantation: The next frontier.
    Transpl Immunol. 2021;68:101431.
    

    >> Share

    
    
19. YANG L, Ma J, He Q, Li X, et al
    Immutol regulates CD4(+)Tregs, CD8(+)Tregs and pDCs via IDO signaling pathway to induce immune tolerance in rat heart allograft transplant.
    Transpl Immunol. 2021;68:101393.
    

    >> Share

    
    August 2021
20. SCHWEIGER M, Erdil T, Di Bernardo S, Balmer C, et al
    Use of induction therapy in pediatric heart transplant recipients in Switzerland - Analysis of the Swiss national database.
    Transpl Immunol. 2021 Aug 2:101443. doi: 10.1016/j.trim.2021.101443.
    

    >> Share

    
    
21. FUJIMOTO K, Uchida K, Yin E, Zhu J, et al
    Analysis of therapeutic potential of monocytic myeloid-derived suppressor cells in cardiac allotransplantation.
    Transpl Immunol. 2021;67:101405.
    

    >> Share

    
    June 2021
22. XI Y, Ma Y, Xie B, Di A, et al
    Vitamin D3 combined with antibody agents suppresses alloreactive memory T-cell responses to induce heart allograft long-term survival.
    Transpl Immunol. 2021;66:101374.
    

    >> Share

    
    May 2021
23. PALMIERI V, Mansueto G, Coscioni E, Maiello C, et al
    Novel biomarkers useful in surveillance of graft rejection after heart transplantation.
    Transpl Immunol. 2021;67:101406.
    

    >> Share

    
    April 2021
24. PAZDERNIK M, Bedanova H, Chen Z, Kautzner J, et al
    Donor specific anti-HLA antibodies and cardiac allograft vasculopathy: A prospective study using highly automated 3-D optical coherence tomography analysis.
    Transpl Immunol. 2021;65:101340.
    

    >> Share

    
    
25. EMOTO S, Shibasaki S, Nagatsu A, Goto R, et al
    Triazolopyrimidine derivative NK026680 and donor-specific transfusion induces CD4(+)CD25(+)Foxp3(+) T cells and ameliorates allograft rejection in an antigen-specific manner.
    Transpl Immunol. 2021;65:101338.
    

    >> Share

    
    February 2021
26. LU J, Liu Y, Wang W, Li P, et al
    Knockdown of miR-146a in regulatory T cells suppresses heart transplantation rejection in mice by increasing autophagy.
    Transpl Immunol. 2021;65:101372.
    

    >> Share

    
    
27. FRITZ NM, Stamminger T, Ramsperger-Gleixner M, Kuckhahn AV, et al
    Cytomegalovirus chemokine receptor M33 knockout reduces chronic allograft rejection in a murine aortic transplant model.
    Transpl Immunol. 2021;64:101359.
    

    >> Share

    
    October 2020
28. LI C, Wang X, Yuan F, Zhao Z, et al
    MiR-669b-3p regulates CD4(+) T cell function by down-regulating indoleamine-2, 3-dioxygenase.
    Transpl Immunol. 2020;62:101320.
    

    >> Share

    
    June 2020
29. TIMOFEEVA OA, Alvarez R, Pelberg J, Yoon E, et al
    Serum dilutions as a predictive biomarker for peri-operative desensitization: An exploratory approach to transplanting sensitized heart candidates.
    Transpl Immunol. 2020;60:101274.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share